
|Articles|July 1, 2001
The American Journal of Managed Care
- July 2001
- Volume 7
- Issue 7
Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
3
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
4
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
5















































